BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25797393)

  • 1. Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery.
    Subramanian N; Kanwar JR; Akilandeswari B; Kanwar RK; Khetan V; Krishnakumar S
    Chem Commun (Camb); 2015 Apr; 51(32):6940-3. PubMed ID: 25797393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
    Shieh YA; Yang SJ; Wei MF; Shieh MJ
    ACS Nano; 2010 Mar; 4(3):1433-42. PubMed ID: 20166743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A label-free activatable aptamer probe for colorimetric detection of cancer cells based on binding-triggered in situ catalysis of split DNAzyme.
    Shi H; Li D; Xu F; He X; Wang K; Ye X; Tang J; He C
    Analyst; 2014 Sep; 139(17):4181-4. PubMed ID: 25037636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of an optical adenosine sensor by conjugating a DNA aptamer with split DNAzyme halves.
    Lu N; Shao C; Deng Z
    Chem Commun (Camb); 2008 Dec; (46):6161-3. PubMed ID: 19082106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An omega-like DNA nanostructure utilized for small molecule introduction to stimulate formation of DNAzyme-aptamer conjugates.
    Liu B; Zhang B; Chen G; Tang D
    Chem Commun (Camb); 2014 Feb; 50(15):1900-2. PubMed ID: 24407587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplified analysis of low-molecular-weight substrates or proteins by the self-assembly of DNAzyme-aptamer conjugates.
    Li D; Shlyahovsky B; Elbaz J; Willner I
    J Am Chem Soc; 2007 May; 129(18):5804-5. PubMed ID: 17432859
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
    Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
    Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polyvalent aptamer system for targeted drug delivery.
    Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
    Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional G-quadruplex aptamers and their application to protein detection.
    Li T; Shi L; Wang E; Dong S
    Chemistry; 2009; 15(4):1036-42. PubMed ID: 19053089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer degradation inhibition combined with DNAzyme cascade-based signal amplification for colorimetric detection of proteins.
    Li J; Jia Y; Zheng J; Zhong W; Shen G; Yang R; Tan W
    Chem Commun (Camb); 2013 Jul; 49(55):6137-9. PubMed ID: 23727767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets1 identified as a novel molecular target of RNA aptamer selected against metastatic cells for targeted delivery of nano-formulation.
    Kaur J; Tikoo K
    Oncogene; 2015 Oct; 34(41):5216-28. PubMed ID: 25639877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-MiRNA Conjugates for Cancer Cell-Targeted Delivery.
    Esposito CL; Catuogno S; de Franciscis V
    Methods Mol Biol; 2016; 1364():197-208. PubMed ID: 26472452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells.
    Ramezanpour M; Daei P; Tabarzad M; Khanaki K; Elmi A; Barati M
    Mol Biol Rep; 2019 Feb; 46(1):207-215. PubMed ID: 30415442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells.
    Ayatollahi S; Salmasi Z; Hashemi M; Askarian S; Oskuee RK; Abnous K; Ramezani M
    Int J Biochem Cell Biol; 2017 Nov; 92():210-217. PubMed ID: 29031805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic applications of AS1411 aptamer, an update review.
    Yazdian-Robati R; Bayat P; Oroojalian F; Zargari M; Ramezani M; Taghdisi SM; Abnous K
    Int J Biol Macromol; 2020 Jul; 155():1420-1431. PubMed ID: 31734366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy.
    Chang M; Yang CS; Huang DM
    ACS Nano; 2011 Aug; 5(8):6156-63. PubMed ID: 21732610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent imaging of cytoplasmic nucleolin in live cells by a functionalized-engineered aptamer.
    Yin J; Chen S; Song Y; Wang H
    Chem Commun (Camb); 2020 Nov; 56(91):14171-14174. PubMed ID: 33156312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splitting a DNAzyme enables a Na
    Zhou W; Ding J; Liu J
    Org Biomol Chem; 2017 Aug; 15(33):6959-6966. PubMed ID: 28792040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly specific recognition of breast tumors by an RNA-cleaving fluorogenic DNAzyme probe.
    He S; Qu L; Shen Z; Tan Y; Zeng M; Liu F; Jiang Y; Li Y
    Anal Chem; 2015 Jan; 87(1):569-77. PubMed ID: 25479319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-based microcantilever biosensor for ultrasensitive detection of tumor marker nucleolin.
    Li H; Bai X; Wang N; Chen X; Li J; Zhang Z; Tang J
    Talanta; 2016 Jan; 146():727-31. PubMed ID: 26695322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.